Abstract
Sarcoma Kaposi is rare and most commonly affects the skin. Herein, we present a patient with ulcerative colitis, who developed intestinal Kaposi’s sarcoma only six months after being diagnosed with ulcerative colitis. Therefore, we may conclude that sarcoma Kaposi was not due to immunosuppressive treatment, as its cutaneous form appeared only twenty days after having started azathioprine, mesalazine and corticosteroids enema. If there is any plausible link between ulcerative colitis and sarcoma Kaposi remains to be elucidated in further large-scale studies.
Highlights
Case ReportVisceral and Cutaneous Sarcoma Kaposi in a Patient with Ulcerative Colitis: Case Report and Review of the Literature
Sarcoma Kaposi is rare and most commonly affects the skin [1]
We present a patient with ulcerative colitis, who developed intestinal Kaposi’s sarcoma only six months after being diagnosed with ulcerative colitis
Summary
Visceral and Cutaneous Sarcoma Kaposi in a Patient with Ulcerative Colitis: Case Report and Review of the Literature. Natalia G Vallianou*, Eleni Geladari, Evangelia Margellou, George Liadakis, Christina Vourlakou and Evangelos Kokkinakis. First Department of Internal Medicine, Evangelismos General Hospital, Athens, Greece
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
